Literature DB >> 22471783

FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.

Timothy Bailey1, Carlos Campos.   

Abstract

Insulin injection pens have improved the ease and convenience of administering insulin for people with diabetes. This article reviews the data on a new prefilled insulin pen, FlexTouch®. FlexTouch has a novel injection mechanism with no push-button extension and a lower injection force than other prefilled pens, and other features including an end-of-dose click; a large dose display; color-coded pens to distinguish different insulin types; an ergonomic design; and compatibility with both NovoTwist® needles and most screw-thread needles. FlexTouch has been demonstrated to deliver insulin consistently and accurately at minimum, half-maximum and maximum doses. In usability studies recruiting patients and healthcare professionals, FlexTouch was easier to use and instilled more confidence than other prefilled pens, and was preferred to other prefilled pens. FlexTouch was also found to be easier to use and was preferred for learning and teaching to use.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22471783     DOI: 10.1586/erd.12.13

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  7 in total

1.  Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection Experience.

Authors:  Ken Fujioka; Thomas Sparre; Lily Yong-Hui Sun; Susanne Krogsgaard; Robert F Kushner
Journal:  J Diabetes Sci Technol       Date:  2015-07-16

2.  The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective.

Authors:  Lalantha Leelarathna; Donna Ashley; Carrie Fidler; Witesh Parekh
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-04       Impact factor: 3.565

3.  User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces.

Authors:  Andreas Schneider; Philipp Richard; Philippe Mueller; Christoph Jordi; Mary Yovanoff; Jakob Lange
Journal:  Patient Prefer Adherence       Date:  2021-02-02       Impact factor: 2.711

4.  Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary.

Authors:  Thomas Sparre; Niels-Aage B Hansen; Anya Sonia Wernersson; Mark Guarraia
Journal:  J Diabetes Sci Technol       Date:  2021-12-01

5.  Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use).

Authors:  Athena Philis-Tsimikas; Meryl Brod; Marcus Niemeyer; Ann Marie Ocampo Francisco; Jeffrey Rothman
Journal:  Adv Ther       Date:  2013-06-29       Impact factor: 3.845

6.  Transjecting growth hormone: continuous nightmare or controlled nuisance? Evaluation of a new needle-free device.

Authors:  Ad A Kaptein
Journal:  Patient Prefer Adherence       Date:  2013-07-24       Impact factor: 2.711

Review 7.  NovoPen Echo(®) insulin delivery device.

Authors:  Jacob Hyllested-Winge; Thomas Sparre; Line Kynemund Pedersen
Journal:  Med Devices (Auckl)       Date:  2016-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.